[ Price : $8.95]
FDA approves a BioCryst Pharmaceuticals supplemental NDA for Rapivab (peramivir injection) expanding the patient population for tr...[ Price : $8.95]
CBER says it plans to issue 14 guidances in three categories in the current calendar year.[ Price : $8.95]
FDA approves Galdermas Restylan Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the ...[ Price : $8.95]
FDA clears an NGMedical 510(k) for its 3D-manufactured titanium cervical interbody BEE cage implant.[ Price : $8.95]
FDA approves a Durect NDA for Posimir (bupivacaine solution) for infiltration use in adults for administration into the subacromia...[ Price : $8.95]
FDA plans a 3/29-30 public workshop on Nitrosamines as Impurities in Drugs; Health Risk Assessment and Mitigation.[ Price : $8.95]
FDA releases safety-related labeling changes for Adamas Gocovri.[ Price : $8.95]
FDA approves a BioCryst Pharmaceuticals supplemental NDA for Rapivab (peramivir injection) expanding the patient population for tr...